Skip to main content

Advertisement

Log in

Circulating anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis and chronic obstructive pulmonary disease

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Anti-cyclic citrullinated peptide (anti-CCP) antibody is highly specific for diagnosing rheumatoid arthritis (RA). Cigarette smoking is a lifestyle and environmental factor associated with anti-CCP production and is strongly associated with chronic obstructive pulmonary disease (COPD). This study assessed levels of anti-CCP antibodies and rheumatoid factor (RF) among patients with RA and COPD. The study sample comprised 63 patients with RA and 70 patients with COPD, all of whom underwent assessment of anti-CCP antibody and RF levels. Testing revealed that 54.2 % of RA patients and 0 % of COPD patients were positive for anti-CCP antibodies. Additionally, 82.5 % of RA patients and 42 % of COPD patients were positive for RF. Among RA patients, levels of anti-CCP antibodies were higher among smokers than among nonsmokers (242.7 ± 128.3 vs. 68.1 ± 112.1, P < 0.001). COPD patients had low titers of RF but were negative for anti-CCP antibodies. The presence of anti-CCP antibodies was a reliable serologic marker in RA diagnosis and was associated with cigarette smoking.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Barra L, Pope J, Bessette L, Haraoui B, Bykerk V (2011) Lack of seroconversion of rheumatoid factor and anti-cyclic citrullinated peptide in patients with early inflammatory arthritis: a systematic literature review. Rheumatology (Oxford) 50:311–316

    Article  CAS  Google Scholar 

  2. Szodoray P, Szabo Z, Kapitany A et al (2010) Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis. Autoimmun Rev 9:140–143

    Article  CAS  PubMed  Google Scholar 

  3. Wiik AS, van Venrooij WJ, Pruijn GJ (2010) All you wanted to know about anti-CCP but were afraid to ask. Autoimmun Rev 10:90–93

    Article  CAS  PubMed  Google Scholar 

  4. Kokkonen H, Mullazehi M, Berglin E et al (2011) Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis. Arthr Res Ther 13:R13

    Article  CAS  Google Scholar 

  5. Rantapaa-Dahlqvist S, de Jong BA, Berglin E et al (2003) Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthr Rheum 48:2741–2749

    Article  Google Scholar 

  6. Scott DL, Wolfe F, Huizinga TW (2010) Rheumatoid arthritis. Lancet 376:1094–1108

    Article  PubMed  Google Scholar 

  7. Svard A, Kastbom A, Soderlin MK, Reckner-Olsson A, Skogh T (2011) A comparison between IgG- and IgA-class antibodies to cyclic citrullinated peptides and to modified citrullinated vimentin in early rheumatoid arthritis and very early arthritis. J Rheumatol 38:1265–1272

    Article  PubMed  Google Scholar 

  8. Goeldner I, Skare TL, de Messias Reason IT, Nisihara RM, Silva MB, da Rosa Utiyama SR (2011) Association of anticyclic citrullinated peptide antibodies with extra-articular manifestations, gender, and tabagism in rheumatoid arthritis patients from southern Brazil. Clin Rheumatol 30:975–980

    Article  PubMed  Google Scholar 

  9. Young KA, Deane KD, Derber LA et al. (2013) Relatives without rheumatoid arthritis show reactivity to anti-citrullinated protein/peptide antibodies which are associated with arthritis-related traits: studies of the etiology of rheumatoid arthritis. Arthr Rheum 65:1995–2004

    Article  CAS  Google Scholar 

  10. Burr ML, Viatte S, Bukhari M et al (2012) Long-term stability of anti-cyclic citrullinated peptide antibody status in patients with early inflammatory polyarthritis. Arthr Res Ther 14:R109

    Article  CAS  Google Scholar 

  11. Lima I, Santiago M (2010) Antibodies against cyclic citrullinated peptides in infectious diseases—a systematic review. Clin Rheumatol 29:1345–1351

    Article  PubMed  Google Scholar 

  12. Bang SY, Lee KH, Cho SK, Lee HS, Lee KW, Bae SC (2010) Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status. Arthr Rheum 62:369–377

    CAS  Google Scholar 

  13. Mahdi H, Fisher BA, Kallberg H et al (2009) Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis. Nat Genet 41:1319–1324

    Article  CAS  PubMed  Google Scholar 

  14. Pistelli R, Ferrara L, Misuraca C, Bustacchini S (2011) Practical management problems of stable chronic obstructive pulmonary disease in the elderly. Curr Opin Pulm Med 17(Suppl 1):S43–S48

    Article  PubMed  Google Scholar 

  15. Brusselle GG, Joos GF, Bracke KR (2011) New insights into the immunology of chronic obstructive pulmonary disease. Lancet 378:1015–1026

    Article  CAS  PubMed  Google Scholar 

  16. Tsoumakidou M, Tzanakis N, Kyriakou D, Chrysofakis G, Siafakas NM (2004) Inflammatory cell profiles and T-lymphocyte subsets in chronic obstructive pulmonary disease and severe persistent asthma. Clin Exp Allergy 34:234–240

    Article  CAS  PubMed  Google Scholar 

  17. Vaguliene N, Zemaitis M, Lavinskiene S, Miliauskas S, Sakalauskas R (2013) Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease. BMC Immunol 14:36

    Article  PubMed Central  PubMed  Google Scholar 

  18. Kilsgard O, Andersson P, Malmsten M et al (2012) Peptidylarginine deiminases present in the airways during tobacco smoking and inflammation can citrullinate the host defense peptide LL-37, resulting in altered activities. Am J Respir Cell Mol Biol 46:240–248

    Article  CAS  PubMed  Google Scholar 

  19. Reynisdottir G, Karimi R, Joshua V et al (2013) Structural lung changes and local anti-citrulline immunity are early features of anti citrullinated-proteins antibodies positive rheumatoid arthritis. Arthr Rheum

  20. Wood AM, de Pablo P, Buckley CD, Ahmad A, Stockley RA (2011) Smoke exposure as a determinant of autoantibody titre in alpha(1)-antitrypsin deficiency and COPD. Eur Respir J 37:32–38

    Article  CAS  PubMed  Google Scholar 

  21. Newkirk MM, Mitchell S, Procino M et al (2012) Chronic smoke exposure induces rheumatoid factor and anti-heat shock protein 70 autoantibodies in susceptible mice and humans with lung disease. Eur J Immunol 42:1051–1061

    Article  CAS  PubMed  Google Scholar 

  22. Ruiz-Esquide V, Gomara MJ, Peinado VI et al (2012) Anti-citrullinated peptide antibodies in the serum of heavy smokers without rheumatoid arthritis. A differential effect of chronic obstructive pulmonary disease? Clin Rheumatol 31:1047–1050

    Article  PubMed  Google Scholar 

  23. Fischer A, Solomon JJ, du Bois RM et al (2012) Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease. Respir Med 106:1040–1047

    Article  PubMed Central  PubMed  Google Scholar 

  24. Klareskog L, Stolt P, Lundberg K et al (2006) A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthr Rheum 54:38–46

    Article  CAS  Google Scholar 

  25. Makrygiannakis D, Hermansson M, Ulfgren AK et al (2008) Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis 67:1488–1492

    Article  CAS  PubMed  Google Scholar 

  26. Kallberg H, Padyukov L, Plenge RM et al (2007) Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. Am J Hum Genet 80:867–875

    Article  PubMed Central  PubMed  Google Scholar 

  27. Michou L, Teixeira VH, Pierlot C et al (2008) Associations between genetic factors, tobacco smoking and autoantibodies in familial and sporadic rheumatoid arthritis. Ann Rheum Dis 67:466–470

    Article  CAS  PubMed  Google Scholar 

  28. Oliveira RD, Junta CM, Oliveira FR, Silva LM, Donadi EA, Louzada-Junior P (2008) Share epitope, citrullinated cyclic peptide antibodies and smoking in Brazilian rheumatoid arthritis patients. Clin Rev Allergy Immunol 34:32–35

    Article  PubMed  Google Scholar 

  29. Klareskog L, Padyukov L, Alfredsson L (2007) Smoking as a trigger for inflammatory rheumatic diseases. Curr Opin Rheumatol 19:49–54

    Article  CAS  PubMed  Google Scholar 

  30. Fan LY, He DY, Wang Q et al (2012) Citrullinated vimentin stimulates proliferation, pro-inflammatory cytokine secretion, and PADI4 and RANKL expression of fibroblast-like synoviocytes in rheumatoid arthritis. Scand J Rheumatol 41:354–358

    Article  CAS  PubMed  Google Scholar 

  31. Vignola MB, Davila S, Cremonezzi D, Simes JC, Palma JA, Campana VR (2012) Evaluation of inflammatory biomarkers associated with oxidative stress and histological assessment of magnetic therapy on experimental myopathy in rats. Electromagn Biol Med 31:320–332

    Article  CAS  PubMed  Google Scholar 

  32. Jonsson T, Thorsteinsson J, Valdimarsson H (1998) Does smoking stimulate rheumatoid factor production in non-rheumatic individuals? APMIS 106:970–974

    Article  CAS  PubMed  Google Scholar 

  33. Hayahara C, Ikeda K, Sakanishi Y, Ota T (2010) Incidence of serum rheumatoid factors in elder non-rheumatic individuals. Rinsho Byori 58:211–215

    CAS  PubMed  Google Scholar 

  34. Korpilahde T, Heliovaara M, Knekt P, Marniemi J, Aromaa A, Aho K (2004) Smoking history and serum cotinine and thiocyanate concentrations as determinants of rheumatoid factor in non-rheumatoid subjects. Rheumatology (Oxford) 43:1424–1428

    Article  CAS  Google Scholar 

  35. Nielsen SF, Bojesen SE, Schnohr P, Nordestgaard BG (2012) Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study. BMJ 345:e5244

    Article  PubMed Central  PubMed  Google Scholar 

  36. Masdottir B, Jonsson T, Manfredsdottir V, Vikingsson A, Brekkan A, Valdimarsson H (2000) Smoking, rheumatoid factor isotypes and severity of rheumatoid arthritis. Rheumatology (Oxford) 39:1202–1205

    Article  CAS  Google Scholar 

  37. Cader MZ, Filer AD, Buckley CD, Raza K (2010) The relationship between the presence of anti-cyclic citrullinated peptide antibodies and clinical phenotype in very early rheumatoid arthritis. BMC Musculoskelet Disord 11:187

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

This study is supported by the Taichung Armed-Forces General Hospital (Grant No. 101-05). We also thank Miss Tzi-Yi Wu for her professional design.

Conflict of interest

The author has no conflicts of interest to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ya-Wen Cheng.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yang, DH., Tu, CC., Wang, SC. et al. Circulating anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis and chronic obstructive pulmonary disease. Rheumatol Int 34, 971–977 (2014). https://doi.org/10.1007/s00296-013-2926-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-013-2926-6

Keywords

Navigation